Skip to content
  • Tuesday, 27 October 2026
  • 4:20 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Scholar Rock Secures Landmark FDA Approval for Isemblyd, Ushering in a New Era of Muscle-Targeted Spinal Muscular Atrophy Treatments
Pharmaceutical R&D

Scholar Rock Secures Landmark FDA Approval for Isemblyd, Ushering in a New Era of Muscle-Targeted Spinal Muscular Atrophy Treatments

Teuku Ryan Sep 15, 2026 0

The United States Food and Drug Administration has officially granted approval to Scholar Rock for Isemblyd (apitegromab), establishing a monumental…

Read More
Neuroscience & Brain Research

King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286

Rifan Muazin Jul 25, 2026 0

Researchers at King’s College London have identified a promising new therapeutic strategy for Alzheimer’s disease by targeting several of the…

Read More
Neuroscience & Brain Research

University of Cambridge Researchers Identify Biological Switch for Nerve Regeneration Using Lab-Grown Human Brain and Spinal Cord Models

Rifan Muazin May 29, 2026 0

The traditional medical consensus that damage to the central nervous system is inherently permanent has been challenged by a landmark…

Read More
Sex Differences in Modifiable Risk Factors of Dementia and Their Associations with CognitionSamsung Biologics to Acquire PolyPeptide Group for SFr1.46 Billion, Expanding Peptide Therapeutics and CDMO CapabilitiesThe Joint Clinical Assessment: Navigating Procedural and Methodological Hurdles in EU Drug EvaluationNature’s Proton Highway Revealed: Scientists Unravel Molecular Secrets of Charge Transport in Biological Systems and Beyond
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ